Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Holding ELTP?
Track your performance easily

Elite Pharmaceuticals (ELTP) Financial Statements

190 Followers

Elite Pharmaceuticals Financial Overview

Elite Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.019; its P/E ratio is 22.72; Elite Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 18.80M$ 17.95M$ 15.54M$ 14.16M$ 9.00M
Gross Profit$ 8.47M$ 8.12M$ 7.04M$ 6.45M$ 4.75M
EBIT$ 882.63K$ 2.22M$ 27.37K$ -2.60M$ 1.42M
EBITDA$ 1.44M$ 2.69M$ 370.97K$ -2.27M$ 1.75M
Net Income Common Stockholders$ 615.77K$ -47.60M$ 706.40K$ 14.97M$ 1.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.41M$ 7.11M$ 5.82M$ 8.65M$ 9.08M
Total Assets$ 87.85M$ 83.65M$ 74.70M$ 70.72M$ 46.50M
Total Debt$ 11.66M$ 11.74M$ 7.89M$ 7.65M$ 7.84M
Net Debt$ 3.26M$ 4.63M$ 2.07M$ -1.00M$ -1.24M
Total Liabilities$ 29.60M$ 26.07M$ 28.28M$ 25.62M$ 16.38M
Stockholders Equity$ 58.25M$ 57.58M$ 46.41M$ 45.09M$ 30.12M
Cash Flow-
Free Cash Flow$ 1.48M$ 1.66M$ -2.80M$ -235.94K$ -2.71M
Operating Cash Flow$ 3.14M$ 2.06M$ -2.40M$ -235.94K$ -2.71M
Investing Cash Flow$ -1.66M$ -403.65K$ -406.01K--
Financing Cash Flow$ -174.91K$ -361.45K$ -30.65K$ -179.50K$ 3.96M
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

Elite Pharmaceuticals Debt to Assets

Elite Pharmaceuticals Cash Flow

Elite Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis